NCT02736487

Brief Summary

The purpose of this research project is to examine whether short-term use of portable air pollution filtration can result in changes in indoor airborne pollutants and impact on cardiovascular and respiratory health outcomes of the inhabitants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

December 10, 2015

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 13, 2016

Completed
Last Updated

April 13, 2016

Status Verified

March 1, 2016

Enrollment Period

1 month

First QC Date

December 10, 2015

Last Update Submit

April 7, 2016

Conditions

Keywords

Air PollutionExposure AssessmentFiltrationCardiovascular OutcomesRespiratory OutcomesShort-term Intervention

Outcome Measures

Primary Outcomes (5)

  • Change from baseline FEV1 (forced expiratory volume in the first second of exhalation) within 2h after the filtration intervention

    FEV1 (forced expiratory volume in the first second of exhalation, unit: liter) was measured by spirometry in all subjects within 2h after the filtration intervention to compare to FEV1 value of study subjects at baseline (i.e. at start of the study).

    Within 2h after the filtration intervention

  • Change from baseline R5 (airway resistance measured at 5Hz) within 2h after the filtration intervention

    R5 (airway resistance measured at 5Hz) was accessed by impulse oscillometry in all subjects within 2h after the filtration intervention to compare to the R5 value of study subjects at baseline (i.e. before the start of intervention).

    Within 2h after the filtration intervention

  • Change in baseline exhaled nitric oxide (eNO) within 2h after the filtration intervention

    Exhaled nitric oxide (eNO) was measured in all subjects within 2h after the filtration intervention to compare to the exhaled nitric oxide measurement of study subjects at baseline (i.e. before the start of intervention). Exhaled breath is collected in air sampling bags, and the concentration of NO was quantified by Thermo Scientific model 42i (NO-NO2-NOx) analyzer.

    Within 2h after the filtration intervention

  • Change in exhaled nitric oxide (eNO) at 6h after filtration intervention compared to baseline

    Exhaled nitric oxide (eNO) was measured in all subjects 6h after filtration intervention to compare to the exhaled nitric oxide measurement of study subjects at baseline (i.e. before the start of intervention). Exhaled breath is collected in air sampling bags, and the concentration of NO was quantified by Thermo Scientific model 42i (NO-NO2-NOx) analyzer.

    6h after filtration intervention

  • Change from baseline PWV (pulse wave velocity) within 2h after the filtration intervention

    PWV (pulse wave velocity) was measured by the VICORDER instrument in all subjects right after filtration intervention to compare to the PWV value measured at baseline (i.e. before the start of intervention).

    Within 2h after the filtration intervention

Secondary Outcomes (6)

  • Change from baseline urinary biomarkers of inflammation and oxidative stress at 0h after the filtration intervention

    At 0h after the filtration intervention

  • Change in baseline urinary biomarkers of inflammation and oxidative stress at 6h after filtration intervention

    6h after filtration intervention

  • Change in baseline urinary biomarkers of inflammation and oxidative stress at 24h after filtration intervention

    24h after filtration intervention

  • Changes in baseline blood biomarkers of inflammation, oxidative stress and coagulation within 1h after filtration intervention

    Within 1h after filtration intervention

  • Changes in baseline blood biomarkers of inflammation, oxidative stress and coagulation right after filtration intervention

    24h after filtration intervention

  • +1 more secondary outcomes

Study Arms (2)

Group A: True-Washout-Sham

ACTIVE COMPARATOR

Subjects in group A receives true air filtration intervention, then at least two weeks of washout period, followed by sham air filtration intervention.

Device: True-Washout-Sham Air Filtration Intervention

Group B: Sham-Washout-True

ACTIVE COMPARATOR

Subjects in group B receives sham air filtration intervention, then at least two weeks of washout period, followed by true air filtration intervention.

Device: Sham-Washout-True Air Filtration Intervention

Interventions

This intervention involved three sequential steps: (1) 12 to 20 hours of true air filtration intervention; (2) at least two weeks of washout period; (3) 12 to 20 hours of sham air filtration intervention. In the indoor environment, the portable filtration device drew room air, sent it through filter and active carbon (for true filtration) or active carbon alone (sham filtration) and then delivered processed air back to room air. In the study the portable filtration device processes 2.8 cubic meter of room air per minute. The washout period lasted for at least two weeks where no filtration intervention was implemented.

Group A: True-Washout-Sham

This intervention involved three sequential steps: (1) 12 to 20 hours of sham air filtration intervention; (2) at least two weeks of washout period; (3) 12 to 20 hours of true air filtration intervention. In the indoor environment, the portable filtration device drew room air, sent it through filter and active carbon (for true filtration) or active carbon alone (sham filtration) and then delivered processed air back to room air. In the study the portable filtration device processes 2.8 cubic meter of room air per minute. The washout period lasted for at least two weeks where no filtration intervention was implemented.

Group B: Sham-Washout-True

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy, non-smoking adults
  • Live in the dormitory building at Shanghai First People's Hospital (South Section).

You may not qualify if:

  • Current smokers
  • Has any of the following diseases: chronic respiratory, cardiovascular, liver, renal, hematological disease; diabetes mellitus;
  • Has any other diseases that may confound or complicate the effects of the intervention
  • Pregnant females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai First People's Hospital

Shanghai, Shanghai Municipality, 201620, China

Location

Study Officials

  • Junfeng Zhang, PhD

    Duke University

    PRINCIPAL INVESTIGATOR
  • Yinping Zhang, PhD

    Tsinghua University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 10, 2015

First Posted

April 13, 2016

Study Start

November 1, 2015

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

April 13, 2016

Record last verified: 2016-03

Locations